HomeNewsScienceCanada’s Dangerous Holdout: While the World Rejects Puberty Blockers for Kids, Ottawa...

Canada’s Dangerous Holdout: While the World Rejects Puberty Blockers for Kids, Ottawa and Medical Bodies Double Down

Ottawa – Canada remains one of the last Western holdouts aggressively promoting puberty blockers, cross-sex hormones, and surgeries for gender-dysphoric minors.

The United States, Australia, New Zealand, and much of Europe have reversed course after rigorous reviews exposed the “gender-affirming” model’s weak evidence base. Britain’s Cass Review prompted the NHS to ban routine puberty blockers for under-18s. Sweden, Finland, Norway, and others now confine these interventions to strict research settings or rare cases. Multiple U.S. states have banned them outright for minors, citing risks of infertility, bone density loss, sexual dysfunction, and failure to resolve underlying mental health issues.

In contrast, the Canadian Paediatric Society and aligned medical associations continue to endorse the full affirmative pathway with minimal safeguards in most provinces. Distressed adolescents—often teenage girls influenced by social media—can be fast-tracked toward lifelong medicalization without thorough assessment of trauma, autism, or comorbidities.

Alberta stands out as a rare voice of caution. The province passed Bill 26 restricting puberty blockers and hormone therapy for those under 16 (with limited exceptions for ages 16-17 requiring parental, physician, and psychologist approval) and banning surgeries for minors. Despite legal challenges and temporary injunctions, courts have allowed the restrictions to proceed, prioritizing child protection over ideology.

Alberta’s sensible stance drew fierce criticism from the Alberta NDP, who accused the government of “hateful” legislation, attacking trans kids, and trampling rights. NDP figures and allies denounced the protections as discriminatory, ignoring the international evidence shift.

This is not evidence-based medicine—it is ideological capture. While other countries safeguard children by pausing or restricting these experimental treatments, federal policymakers and most Canadian medical leaders refuse a national review. Their stubborn defiance of the emerging consensus leaves vulnerable youth at risk of irreversible harm.

Canada’s holdout is not compassion; it is reckless negligence. Alberta’s approach shows leadership—the rest of Canada should follow before more children pay the price.

RELATED ARTICLES

Most Popular

Recent Comments